Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial Article Early Access

cited authors

  • Mahaffey, Kenneth W.; Tuttle, Katherine R.; Arici, Mustafa; Baeres, Florian M. M.; Bakris, George; Charytan, David M.; Cherney, David Z., I; Chernin, Gil; Correa-Rotter, Ricardo; Gumprecht, Janusz; Idorn, Thomas; Pugliese, Giuseppe; Rasmussen, Ida Kirstine Bull; Rasmussen, Soren; Rossing, Peter; Sokareva, Ekaterina; Mann, Johannes F. E.; Perkovic, Vlado; Pratley, Richard; FLOW Trial Comm & Investigators

Publication Date

  • August 30, 2024

webpage

published in

category

keywords

  • Cardiovascular outcomes
  • Chronic kidney disease
  • Semaglutide
  • Type 2 diabetes